About Us
Innovative Solutions and Excellence in CRDMO
OUR MISSION
LAXAI partners with pharmaceutical and biotech companies to solve their most complex discovery and CMC challenges through a collaborative model that puts our interests in alignment with theirs.
We provide world-class process R&D, hazard-competent chemistry, and end-to-end manufacturing capabilities—from discovery through commercial scale—with a commitment to quality, safety, and regulatory excellence that our partners can depend on.
Our Commitment
- Shared Success: We invest in early-stage development at cost, earning the right to grow alongside our partners.
- Technical Excellence: We tackle the chemistry others avoid, delivering 99.5% project success.
- True Partnership: We build sustainable, long-term relationships.
- Transparency & Integrity: Complete honesty about capabilities, timelines, and costs.
We don’t just provide services; we collaborate to add genuine value at every stage of the development journey.
OUR VISION
To be the most trusted collaborative partner in small molecule discovery, development and manufacturing, transforming how pharmaceutical and biotech companies bring life-changing therapies to patients through shared commitment, technical excellence, and aligned success.
Board Member

Vamsi Maddipatla
Chairman and MD

Nikhil Puri
Board Member

Susan Bilings, PHD
Board Member

Mark Lan Robbins
Board Member
Our Team

Vamsi Maddipatla
Chairman and MD

Dr. D.A. Jeyaraj
President LAXAI Discovery Services

Michael McGeary
Senior director, business development

Dr. Steve Kendall
Vice president, business development

Ramesh Mullangi, PHD
EVP, Preclinical Biology and DMPK

John L. Dillon
Scientific Advisor
Life at LAXAI























